Cargando…
Efficacy of 14-day concomitant quadruple therapy and 14-day high-dose dual therapy on H. pylori eradication
AIM: We compared the efficacy of two different regimens for H. pylori eradication in areas with high antibiotic resistance. BACKGROUND: Helicobacter pylori (H. pylori) is a gram-negative bacillus that has a strong association with chronic gastritis and peptic ulcer disease. Different regimens with v...
Autores principales: | Yadollahi, Behsood, Valizadeh Toosi, Seyed Mohammad, Bari, Zohreh, Fakheri, Hafez, Maleki, Iradj, Taghvaei, Tarang, Hosseini, Vahid, Kazemi, Arash, Shokri-Afra, Hajar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275744/ https://www.ncbi.nlm.nih.gov/pubmed/35845300 |
Ejemplares similares
-
Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter
pylori eradication
por: Kazemi Veysari, Arash, et al.
Publicado: (2023) -
A Comparison between 10-day and 12-day Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Bari, Zohreh, et al.
Publicado: (2020) -
Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015) -
A Comparison between Moderate- and High-dose Furazolidone in Triple Regimens for Helicobacterpylori Eradication in Iran
por: Hosseini, Vahid, et al.
Publicado: (2014) -
A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Alhooei, Saman, et al.
Publicado: (2016)